Ozempic Is Costing Grocery Stores Billions
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus
Weight loss drugs may lower risk of dementia, stroke: Study
Some popular weight loss drugs may lower the risk of dementia and stroke for patients with Type 2 diabetes and obesity, new research published in JAMA Network suggests. Patients taking semaglutide or tirzepatide medications — active ingredients in weight loss drugs such as Ozempic, Mounjaro and Wegovy — showed a lower risk of developing certain […]
GLP-1 Weight Loss Drugs Reshape Modern Dating Lives
Post Content
Employers are scrambling to cut costs and health care benefits are on the chopping block
Good morning! Health care costs have been rising for years, and finding a way to shoulder that burden and keep benefit prices low has been top of mind for employers. But companies are reaching their limit, and becoming more willing to push costs onto their employees, according to a new report. Around 51% of companies […]
GLP-1 Receptor Agonists Linked to Increased Testosterone in Men with Obesity
submitted by /u/Easy-Examiner [link] [comments]
Experts recommend healthy lifestyle changes alongside GLP-1 drug use
GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything at all.
GLP-1 Agonists Like Ozempic May Trigger Dangerous Gastrointestinal Side Effects
Widely used diabetes medications from the GLP‑1 receptor agonist class, such as semaglutide found in Ozempic, may significantly raise the risk of developing gastroesophageal reflux disease (GERD) and related complications, according to a new study by McGill University and the Lady Davis Institute in Montreal. The findings were published in the journal Annals of Internal […]